Vascular Annual Meeting

Provided by the
Society for Vascular Surgery®

SS16. Thirty Day Mortality from Reintervention or Readmission Following Endovascular and Open Repair of Abdominal Aortic Aneurysms in the United States Medicare Population

Marc L. Schermerhorn1, Kristina A. Giles1, A. James O'Malley2, Philip Cotterill2, Frank B. Pomposelli1, Bruce E. Landon2
1Beth Israel Deaconess Medical Center, Boston, MA; 2Harvard Medical School, Boston, MA

OBJECTIVES: Late survival is similar after EVAR and open AAA repair (OAR) despite a perioperative benefit with EVAR. AAA-related reinterventions are more common after EVAR while laparotomy related reinterventions are more common after OAR. The impact of reinterventions on survival, however, is unknown.

METHODS: Using propensity score matched Medicare beneficiaries (n=45,652) undergoing EVAR and OAR from 2001-2004, AAA and laparotomy-related reinterventions through 2006 were identified. A hierarchical severity scheme was utilized within each hospitalization to avoid counting multiple adjunctive procedures. Hospitalizations for ruptured AAA without repair and for bowel obstruction or ventral hernia without abdominal surgery as well as amputations were also recorded. 30 day mortality was calculated for each reintervention or readmission.

RESULTS: Overall reinterventions or readmissions were similar between repair methods but slightly more common after EVAR (Table 1). EVAR patients had more ruptures (mortality 27%). EVAR patients also had more AAA-related reinterventions (mortality 5.6%), the majority of which were minor endovascular reinterventions (mortality 3.0%). However, minor open (mortality 6.9%) and major reinterventions (mortality 12.1%) were also more common after EVAR than open repair. OAR patients had more laparotomy related reinterventions (mortality 8.1%) and readmissions without surgery (mortality 10.9%). Overall 30 day mortality after any reintervention or readmission was higher after EVAR than OAR (9.8% vs 7.5%, p<0.001).

CONCLUSIONS: Overall reintervention and readmission, and their associated 30 day mortality, are higher after EVAR with up to 6 years of follow-up which likely contributes to loss of late survival benefit after EVAR.

AUTHOR DISCLOSURES: M.L. Schermerhorn, Gore Unrestricted Educational Grant; Endologix DSMB Grant; K.A. Giles, None; A. O'Malley, None; P. Cotterill, None; F.B. Pomposelli, None; B.E. Landon, Gore Unrestricted Educational Grant.
 
Table 1.

Society for Vascular Surgery - 633 N. St. Clair, 24th Floor; Chicago, IL 60611; Phone: 312-334-2300 or 800-258-7188; Fax: 312-334-2320; Email: vascular@vascularsociety.org
© 2010 VascularWeb. All rights reserved. Use of the VascularWeb site constitutes acceptance of all of the policies, rules and regulations for the site.